Sentec Blood Glucose Monitoring System

untitled
Sentec’s blood glucose monitoring system consists of a
hand held meter, a lancet and a cassette (Photo: Sentec Pte Ltd)


In 2014, the global prevalence of diabetes was estimated to be 9% among adults aged 18 and above, according to the World Health Organisation (WHO)1. The organisation says early diagnosis can be achieved through inexpensive blood testing and treatment of diabetes would involve lowering blood glucose and the levels of other known risk factors that damage blood vessels2

A common practice to monitor blood glucose levels among diabetics is to use glucose monitoring devices. For such devices, a blood sample is taken and place on a test strip, which is in turn placed into a meter to calculate the glucose level.

Local medical technology company, Sentec Pte Ltd, has developed a device that eliminates the need for individual test strips by placing multiple test zones on a continuous test tape. The device integrates a hand-held meter, a lancet and an electrochemical biosensor in a cassette. A patient uses the lancet to prick his or her finger, which has a continuous test tape attached to it. This is then inserted into the cassette to generate the blood glucose readings after a few seconds. The continuous test tape allows up to 100 tests of blood samples.

 

sentec-cassette

This innovative and nifty solution is more hygienic as it eliminates “bloody” test strips and makes it possible for a diabetic to monitor his or her blood sugar discreetly and conveniently, anytime and anywhere, without the hassle of carrying a separate meter, lancer and a container of test strips. Glycemic readings can be transferred wirelessly to caregivers and doctors in real-time using blue-tooth technology. 

“Diabetes is a global epidemic. There are an estimated 285  million diabetics worldwide, with more 40% of them in Asia. The number is expected to grow by 30% to over 400 million by 2025,” said Dr Roobik Azarnia, president and chief scientific officer of Sentec. “Sentec enables a lower cost, safer and more convenient way for those with diabetes to measure their glucose levels,” he said. 

This prototype is in development stage and will require regulatory clearance. It is not available for sale at present.

Sentec Pte Ltd is a Singapore-based developmental stage in-vitro diagnostics company that focuses on the self-monitoring of blood glucose. This research has received funding from Get2Volume, an incubator under the NRF’s Technological Incubation Scheme. 



1 Source: Global status report on noncommunicable diseases 2014. Geneva, World Health    
                  Organization, 2012.
2 Source: World Health Organisation Media Factsheet No. 312 - Diabetes.
                  URL: http://www.who.int/mediacentre/factsheets/fs312/en/ 
 

Back to top